David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Invesco BuyBack Achievers ETF
PKW
$1.79B
| $241K | ﹤0.01% |
2,140
| – | – |
|
3727
PUT
Charles River Laboratories
CRL
$14.3B
| $241K | ﹤0.01% |
1,600
| – | – |
|
3728
Dr. Reddy's Laboratories
RDY
$10.2B
| $240K | ﹤0.01% |
18,210
-411,677
| -96% | -$5.68M |
|
3729
The RMR Group
RMR
$336M
| $240K | ﹤0.01% |
+14,406
| New | +$265K |
|
3730
Northern Oil and Gas
NOG
$2.86B
| $239K | ﹤0.01% |
7,900
-105,054
| -93% | -$3.6M |
|
3731
Cullinan Oncology
CGEM
$1.4B
| $238K | ﹤0.01% |
31,494
-17,438
| -36% | -$167K |
|
3732
Argan
AGX
$6.57B
| $238K | ﹤0.01% |
1,812
| – | – |
|
3733
California Water Service
CWT
$3.14B
| $237K | ﹤0.01% |
4,895
-32,302
| -87% | -$1.47M |
|
3734
Invesco China Technology ETF
CQQQ
$3.01B
| $236K | ﹤0.01% |
+5,329
| New | +$235K |
|
|
3735
PUT
Argan
AGX
$6.57B
| $236K | ﹤0.01% |
+1,800
| New | +$251K |
|
3736
CALL
Novavax
NVAX
$1.46B
| $236K | ﹤0.01% |
36,800
-126,700
| -77% | -$1.05M |
|
3737
First Commonwealth Financial
FCF
$2.12B
| $236K | ﹤0.01% |
+15,170
| New | +$246K |
|
3738
Civista Bancshares
CIVB
$573M
| $234K | ﹤0.01% |
11,988
+215
| +2% | +$4.4K |
|
|
ARTY
3739
iShares Future AI & Tech ETF
ARTY
$3.84B
| $234K | ﹤0.01% |
7,428
| – | – |
|
3740
Camden National
CAC
$961M
| $233K | ﹤0.01% |
+5,760
| New | +$248K |
|
3741
Orrstown Financial Services
ORRF
$828M
| $233K | ﹤0.01% |
+7,756
| New | +$260K |
|
3742
Miller Industries
MLR
$644M
| $233K | ﹤0.01% |
+5,493
| New | +$319K |
|
3743
Amplitude
AMPL
$1.64B
| $233K | ﹤0.01% |
22,832
-25,664
| -53% | -$303K |
|
3744
CALL
Allegiant Air
ALGT
$2.23B
| $232K | ﹤0.01% |
4,500
-24,300
| -84% | -$1.95M |
|
3745
PUT
MGP Ingredients
MGPI
$384M
| $232K | ﹤0.01% |
+7,900
| New | +$264K |
|
3746
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.89B
| $232K | ﹤0.01% |
2,920
-2,974
| -50% | -$256K |
|
3747
Interparfums
IPAR
$3.74B
| $232K | ﹤0.01% |
2,037
-481
| -19% | -$63.9K |
|
3748
Franco-Nevada
FNV
$52.1B
| $232K | ﹤0.01% |
1,470
-123,816
| -99% | -$17.3M |
|
3749
Crocs
CROX
$6.03B
| $231K | ﹤0.01% |
2,177
-114,775
| -98% | -$11.9M |
|
3750
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$266M
| $231K | ﹤0.01% |
6,050
| – | – |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.